Holdsworth-Carson Sarah J, Chung Jessica, Machalek Dorothy A, Li Rebecca, Jun Byung Kyu, Griffiths Meaghan J, Churchill Molly, McCaughey Tristan, Nisbet Debbie, Dior Uri, Donoghue Jacqueline F, Montgomery Grant W, Reddington Charlotte, Girling Jane E, Healey Martin, Rogers Peter A W
Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne and Gynaecology Research Centre, Royal Women's Hospital, Grattan St & Flemington Rd, Parkville, VIC, 3052, Australia.
The Julia Argyrou Endometriosis Centre, Epworth HealthCare, Ground Floor, 185-187 Hoddle Street, Richmond, VIC, 3121, Australia.
BMC Med. 2024 Aug 7;22(1):320. doi: 10.1186/s12916-024-03508-7.
Despite surgical and pharmacological interventions, endometriosis can recur. Reliable information regarding risk of recurrence following a first diagnosis is scant. The aim of this study was to examine clinical and survey data in the setting of disease recurrence to identify predictors of risk of endometriosis recurrence.
This observational study reviewed data from 794 patients having surgery for pelvic pain or endometriosis. Patients were stratified into two analytic groups based on self-reported or surgically confirmed recurrent endometriosis. Statistical analyses included univariate, followed by multivariate logistic regression to identify risk factors of recurrence, with least absolute shrinkage and selection operator (Lasso) regularisation. Risk-calibrated Supersparse Linear Integer Models (RiskSLIM) and survival analyses (with Lasso) were undertaken to identify predictive features of recurrence.
Several significant features were repeatedly identified in association with recurrence, including adhesions, high rASRM score, deep disease, bowel lesions, adenomyosis, emergency room attendance for pelvic pain, younger age at menarche, higher gravidity, high blood pressure and older age. In the surgically confirmed group, with a score of 5, the RiskSLIM method was able to predict the risk of recurrence (compared to a single diagnosis) at 95.3% and included adenomyosis and adhesions in the model. Survival analysis further highlighted bowel lesions, adhesions and adenomyosis.
Following an initial diagnosis of endometriosis, clinical decision-making regarding disease management should take into consideration the presence of bowel lesions, adhesions and adenomyosis, which increase the risk of endometriosis recurrence.
尽管有手术和药物干预,子宫内膜异位症仍可能复发。关于首次诊断后复发风险的可靠信息很少。本研究的目的是检查疾病复发情况下的临床和调查数据,以确定子宫内膜异位症复发风险的预测因素。
这项观察性研究回顾了794例因盆腔疼痛或子宫内膜异位症接受手术的患者的数据。根据自我报告或手术确诊的复发性子宫内膜异位症,将患者分为两个分析组。统计分析包括单变量分析,然后进行多变量逻辑回归以确定复发的风险因素,并采用最小绝对收缩和选择算子(Lasso)正则化。进行风险校准的超稀疏线性整数模型(RiskSLIM)和生存分析(采用Lasso)以确定复发的预测特征。
反复发现几个与复发相关的显著特征,包括粘连、高rASRM评分、深部疾病、肠道病变、子宫腺肌病、因盆腔疼痛到急诊室就诊、初潮年龄较小、妊娠次数较多、高血压和年龄较大。在手术确诊组中,RiskSLIM方法得分为5,能够预测复发风险(与单一诊断相比)为95.3%,模型中包括子宫腺肌病和粘连。生存分析进一步突出了肠道病变、粘连和子宫腺肌病。
在首次诊断子宫内膜异位症后,关于疾病管理的临床决策应考虑肠道病变、粘连和子宫腺肌病的存在,这些因素会增加子宫内膜异位症复发的风险。